Abstract
Purpose of Review
The use of spinal cord stimulation (SCS) has widely increased in terms of neuromodulation for patients with chronic pain. This article discusses the most recent evidence of various indications of SCS to manage pain and improve the quality of life in patients.
Recent Findings
The Food and Drug Administration (FDA) has approved SCS for specific etiologies of chronic pain. The ongoing effort has been dedicated to improving stimulation mechanisms and expanding indications of SCS with promising results. It is essential for providers to be aware of the most current technology and approved and potential indications of SCS to maximize outcomes for each individual patient.
Summary
SCS can manage chronic pain for patients and improve their function and quality of life. Specific FDA-approved indications are currently available for patients and can be used for managing debilitating pain. The development of non-FDA indications for SCS is ongoing and provides hope for patients with refractory pain.
Similar content being viewed by others
Data Availability
No datasets were generated or analyzed during the current study.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Sdrulla AD, Guan Y, Raja SN. Spinal cord stimulation: clinical efficacy and potential mechanisms. Pain Pract. 2018;18(8):1048–67. https://doi.org/10.1111/papr.12692.
• Deer TR, Falowski SM, Moore GA, et al. Passive recharge burst spinal cord stimulation provides sustainable improvements in pain and psychosocial function: 2-year results from the TRIUMPH study. Spine (Phila Pa 1976). 2022;47(7):548–56. https://doi.org/10.1097/BRS.0000000000004283. (This study is significant in that it demonstrated that the burst SCS can result in positive long-term outcomes for the management of chronic back pain including improving function, quality of life, pain intensity, and psychological distress.).
Ali R, Schwalb JM. History and future of spinal cord stimulation. Neurosurgery. 2023 https://doi.org/10.1227/neu.0000000000002654
Krames E. Spinal cord stimulation: indications, mechanism of action, and efficacy. Curr Rev Pain. 1999;3(6):419–26. https://doi.org/10.1007/s11916-999-0068-z.
Nissen M, Ikaheimo TM, Huttunen J, Leinonen V, von Und Zu, Fraunberg M. Long-term outcome of spinal cord stimulation in failed back surgery syndrome: 20 years of experience with 224 consecutive patients. Neurosurgery. 2019;84(5):1011–8. https://doi.org/10.1093/neuros/nyy194.
Masopust V, Holubova J, Skalicky P, et al. Neuromodulation in the treatment of postoperative epidural fibrosis: comparison of the extent of epidural fibrosis and the effect of stimulation. Physiol Res. 2021;70(3):461–8. https://doi.org/10.33549/physiolres.934617.
North RB, Calodney A, Bolash R, et al. Redefining spinal cord stimulation “trials”: a randomized controlled trial using single-stage wireless permanent implantable devices. Neuromodulation. 2020;23(1):96–101. https://doi.org/10.1111/ner.12970.
Russo M, Cousins MJ, Brooker C, et al. Effective relief of pain and associated symptoms with cl osed-loop spinal cord stimulation system: preliminary results of the Avalon study. Neuromodulation. 2018;21(1):38–47. https://doi.org/10.1111/ner.12684.
Brooker C, Russo M, Cousins MJ, et al. ECAP-controlled closed-loop spinal cord stimulation efficacy and opioid reduction over 24-months: final results of the prospective, multicenter, open-label Avalon study. Pain Pract. 2021;21(6):680–91. https://doi.org/10.1111/papr.13008.
•• Mekhail N, Levy RM, Deer TR, et al. Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trial. Lancet Neurol. 2020;19(2):123–34. https://doi.org/10.1016/S1474-4422(19)30414-4. (Findings from this study demonstrated that closed-loop stimulation provided more meaningful pain relief than open-loop spinal cord stimulation. This suggests management options in SCS should be considered for various patients.).
De Ridder D, Plazier M, Kamerling N, Menovsky T, Vanneste S. Burst spinal cord stimulation for limb and back pain. World Neurosurg. 2013;80(5):642-649e1. https://doi.org/10.1016/j.wneu.2013.01.040.
Graham DT, Lambert M, Mirzadeh Z, Ponce FA. Factors contributing to spinal cord stimulation outcomes for chronic pain. Neuromodulation. 2022;25(1):145–54. https://doi.org/10.1111/ner.13515.
Hagedorn JM, Falowski SM, Blomme B, Capobianco RA, Yue JJ. Burst spinal cord stimulation can attenuate pain and its affective components in chronic pain patients with high psychological distress: results from the prospective, international TRIUMPH study. Spine J. 2022;22(3):379–88. https://doi.org/10.1016/j.spinee.2021.08.005.
Odonkor C, Kwak R, Ting K, Hao D, Collins B, Ahmed S. Fantastic four: age, spinal cord stimulator waveform, pain localization and history of spine surgery influence the odds of successful spinal cord stimulator trial. Pain Physician. 2020;23(1):E19–30.
Sanders RA, Hoelzer BC, Bendel MA, et al. Utilization of leads after permanent implant in spinal cord stimulator systems. Pain Pract. 2018;18(5):562–7. https://doi.org/10.1111/papr.12644.
Vallejo R, Chakravarthy K, Will A, Trutnau K, Dinsmoor D. A new direction for closed-loop spinal cord stimulation: combining contemporary therapy paradigms with evoked compound action potential sensing. J Pain Res. 2021;14:3909–18. https://doi.org/10.2147/jpr.S344568.
Al-Kaisy A, Palmisani S, Smith TE, et al. 10 kHz high-frequency spinal cord stimulation for chronic axial low back pain in patients with no history of spinal surgery: a preliminary, prospective, open label and proof-of-concept study. Neuromodulation. 2017;20(1):63–70. https://doi.org/10.1111/ner.12563.
Dorenkamp BC, Popovich JM, O’Hagan K, Flood JN. P128 Spinal cord stimulation decreases pain and disability in patients with non-radicular, nonoperative chronic axial low back pain. Spine J. 2020;20(9):S207. https://doi.org/10.1016/j.spinee.2020.05.526.
Al-Kaisy A, Palmisani S, Smith TE, et al. Long-term improvements in chronic axial low back pain patients without previous spinal surgery: a cohort analysis of 10-khz high-frequency spinal cord stimulation over 36 months. Pain Med. 2018;19(6):1219–26. https://doi.org/10.1093/pm/pnx237.
Mehta V, Poply K, Ahmad A, et al. Effectiveness of high dose spinal cord stimulation for non-surgical intractable lumbar radiculopathy - HIDENS Study. Pain Pract. 2022;22(2):233–47. https://doi.org/10.1111/papr.13087.
Campwala Z, Datta P, DiMarzio M, Sukul V, Feustel PJ, Pilitsis JG. Spinal cord stimulation to treat low back pain in patients with and without previous spine surgery. Neuromodulation. 2021;24(8):1363–9. https://doi.org/10.1111/ner.13333.
Awad AJ, Jex B, Kirchen G, Peterson S, Endrizzi SA, Pahapill PA. Spinal cord stimulation for neurogenic claudication associated with lumbar spinal stenosis. Pain Physician. 2021;24(8):E1247–53.
Kemler MA, de Vet HC, Barendse GA, van den Wildenberg FA, van Kleef M. Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. J Neurosurg. 2008;108(2):292–8. https://doi.org/10.3171/JNS/2008/108/2/0292.
Ghosh PE, Gill JS, Simopoulos T. The evolving role of high-frequency spinal cord stimulation as salvage therapy in neurostimulation. Pain Pract. 2020;20(7):706–13. https://doi.org/10.1111/papr.12898.
Canos-Verdecho A, Abejon D, Robledo R, et al. Randomized prospective study in patients with complex regional pain syndrome of the upper limb with high-frequency spinal cord stimulation (10-kHz) and low-frequency spinal cord stimulation. Neuromodulation. 2021;24(3):448–58. https://doi.org/10.1111/ner.13358.
• Petersen EA, Stauss TG, Scowcroft JA, et al. Effect of high-frequency (10-kHz) spinal cord stimulation in patients with painful diabetic neuropathy: a randomized clinical trial. JAMA Neurol. 2021;78(6):687–98. https://doi.org/10.1001/jamaneurol.2021.0538. (The results of this study suggest that 10-kHz SCS can effectively manage refractory peripheral diabetic neuropathy. Specifically, SCS can improve pain intensity as well as quality of life.).
Chakravarthy K, Kent AR, Raza A, Xing F, Kinfe TM. Burst spinal cord stimulation: review of preclinical studies and comments on clinical outcomes. Neuromodulation. 2018;21(5):431–9. https://doi.org/10.1111/ner.12756.
Langford B, Hunt C, Lerman A, Mauck WD. Pre-operative assessment of patients undergoing spinal cord stimulation for refractory angina pectoris. Pain Med. 2021;22(11):2763–7. https://doi.org/10.1093/pm/pnab105.
Lanza GA, Grimaldi R, Greco S, et al. Spinal cord stimulation for the treatment of refractory angina pectoris: a multicenter randomized single-blind study (the SCS-ITA trial). Pain. 2011;152(1):45–52. https://doi.org/10.1016/j.pain.2010.08.044.
Kumar K, Toth C, Nath RK, Verma AK, Burgess JJ. Improvement of limb circulation in peripheral vascular disease using epidural spinal cord stimulation: a prospective study. J Neurosurg. 1997;86(4):662–9. https://doi.org/10.3171/jns.1997.86.4.0662.
Piedade GS, Vesper J, Reichstein D, Dauphin AK, Damirchi S. Spinal cord stimulation in non-reconstructable critical limb ischemia: a retrospective study of 71 cases. Acta Neurochir (Wien). 2023;165(4):967–73. https://doi.org/10.1007/s00701-022-05448-8.
Augustinsson LE. Epidural spinal electrical stimulation in peripheral vascular disease. Pacing Clin Electrophysiol. 1987;10(1 Pt 2):205–6. https://doi.org/10.1111/j.1540-8159.1987.tb05948.x.
Jivegard LE, Augustinsson LE, Holm J, Risberg B, Ortenwall P. Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study. Eur J Vasc Endovasc Surg. 1995;9(4):421–5. https://doi.org/10.1016/s1078-5884(05)80010-3.
Klinkova A, Kamenskaya O, Ashurkov A, et al. The clinical outcomes in patients with critical limb ischemia one year after spinal cord stimulation. Ann Vasc Surg. 2020;62:356–64. https://doi.org/10.1016/j.avsg.2018.12.093.
Romero-Serrano E, Esparza-Minana JM. Spinal cord stimulation in the approach to chronic pelvic pain: a case report and literature review. Medicine (Baltimore). 2021;100(52):e28379. https://doi.org/10.1097/MD.0000000000028379.
Sankarasubramanian V, Chiravuri S, Mirzakhalili E, et al. Quantitative sensory testing of spinal cord and dorsal root ganglion stimulation in chronic pain patients. Neuromodulation. 2021;24(4):672–84. https://doi.org/10.1111/ner.13329.
Mekhail N, Costandi S, Saweris Y, Armanyous S, Chauhan G. Impact of biological sex on the outcomes of spinal cord stimulation in patients with chronic pain. Pain Pract. 2022;22(4):432–9. https://doi.org/10.1111/papr.13097.
Texakalidis P, Tora MS, Nagarajan P, Keifer OP Jr, Boulis NM. High cervical spinal cord stimulation for occipital neuralgia: a case series and literature review. J Pain Res. 2019;12:2547–53. https://doi.org/10.2147/JPR.S214314.
Falowski SM, Provenzano DA, Xia Y, Doth AH. Spinal cord stimulation infection rate and risk factors: results from a United States payer database. Neuromodulation. 2019;22(2):179–89. https://doi.org/10.1111/ner.12843.
Leplus A, Voirin J, Cuny E, et al. Is spinal cord stimulation still effective after one or more surgical revisions? Neuromodulation. 2023;26(5):1102–8. https://doi.org/10.1016/j.neurom.2023.03.009.
Patel SK, Gozal YM, Saleh MS, Gibson JL, Karsy M, Mandybur GT. Spinal cord stimulation failure: evaluation of factors underlying hardware explantation. J Neurosurg Spine 2019:1–6. https://doi.org/10.3171/2019.6.SPINE181099
Rosenow JM, Stanton-Hicks M, Rezai AR, Henderson JM. Failure modes of spinal cord stimulation hardware. J Neurosurg Spine. 2006;5(3):183–90. https://doi.org/10.3171/spi.2006.5.3.183.
Antonovich DD, Gama W, Ritter A, et al. Reoperation rates of percutaneous and paddle leads in spinal cord stimulator systems: a single-center retrospective analysis. Pain Med. 2021;22(1):34–40. https://doi.org/10.1093/pm/pnaa215.
Zarrin DA, Wilson BR, Teton ZE, Sheldon BL, Dorsi MJ. The role of vancomycin powder during spinal cord stimulator implantation: a case series and review of the literature. World Neurosurg. 2021;156:e72–6. https://doi.org/10.1016/j.wneu.2021.08.141.
Pino IP, Nightingale TE, Hoover C, et al. The safety of epidural spinal cord stimulation to restore function after spinal cord injury: post-surgical complications and incidence of cardiovascular events. Spinal Cord. 2022;60(10):903–10. https://doi.org/10.1038/s41393-022-00822-w.
Author information
Authors and Affiliations
Contributions
EJ, TA, JK, and SK were responsible for conception and design. SK provided administrative support. All authors wrote the manuscript text. All authors reviewed and gave final approval of the manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
Esha Jain, Oranicha Jumreornvong, Tariq AlFarra, Jung H. Kim, Darryl Brown, and Soo Y. Kim declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jain, E., Jumreornvong, O., AlFarra, T. et al. Spinal Stimulators: Review of the Current Evidence. Curr Phys Med Rehabil Rep 12, 210–216 (2024). https://doi.org/10.1007/s40141-024-00445-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40141-024-00445-7